Efficacy and Safety of Divozilimab in Patients With Neuromyelitis Optica Spectrum Disorders (AQUARELLE)
Status:
Recruiting
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to study the efficacy and safety of BCD-132 (divozilimab)
in subjects with neuromyelitis optica spectrum disorders (NMOSD).